Current Valuation
N/A
As of July 30, 2025
Total Funding Raised
$66.5M
Last Round
Debt - General

Amount undisclosed

Last Funding
Jul 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Prognos Health is currently valued at N/A as of July 30, 2025. The company has raised a total of $66.5M in funding.

Investment Perspective

Prognos Health's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Prognos Health Valuation Updates

Get notified when Prognos Health raises new funding or valuation changes

What is Prognos Health Worth in 2025?

As of 2025, Prognos Health is valued at N/A, based on the company's Debt - General funding round in July 30, 2025. This valuation positions Prognos Health as one of the leading private companies in the sector.

Prognos Health Valuation History

Prognos Health's funding history demonstrates steady growth and investor confidence.

How Prognos Health Valuation is Determined

Private company valuations like Prognos Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Prognos Health Valuation FAQs

Is Prognos Health profitable?

Prognos Health has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Prognos Health's valuation compare to competitors?

Prognos Health is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Prognos Health IPO?

Prognos Health has not announced plans for an initial public offering. Until an IPO, investors can access Prognos Health shares through secondary market platforms.